Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Treatment With Acetyl-Choline Esterase Inhibitors in Children With Autism Spectrum Disorders

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2016 by Sheba Medical Center
Sponsor:
Collaborator:
The Israeli Society of Clinical Pediatrics (HIPAK)
Information provided by (Responsible Party):
Dr. Lidia Gabis MD, Sheba Medical Center
ClinicalTrials.gov Identifier:
NCT01098383
First received: March 11, 2010
Last updated: October 13, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2017
  Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)